Navigation Links
Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12
Date:2/4/2008

NEW YORK, Feb. 4 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules using its eligen(R) technology, today announced that the company will present at the BIO CEO & Investor Conference on February 12, 2008 at the Waldorf Astoria Hotel in New York City.

Michael V. Novinski, President and Chief Executive Officer of Emisphere, will present for the company at 2:45 PM in the Lexington Suite of the Hotel. Gary Riley, BVSc, MVSc, Vice President, Nonclinical Development and Applied Biology, will co-present.

For more information on the BIO CEO & Investor Conference, including registration, hotel accommodations and an up-to-date program, please visit the conference Web site at http://ceo.bio.org/opencms/ceo/2008/index.jsp.

About Emisphere Technologies, Inc.

Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules using its eligen(R) technology. These molecules and compounds could be currently available or in development. Such molecules are usually delivered by injection; in many cases, their benefits are limited due to poor bioavailability, slow on-set of action or variable absorption. The eligen(R)technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal. The web site is: http://www.emisphere.com.

Safe Harbor Statement Regarding Forward-Looking Statements

The statements in this release and or
'/>"/>

SOURCE Emisphere Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
3. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
4. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
5. Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
6. Emisphere Technologies, Inc. Moves Into New Corporate Headquarters
7. Emisphere to Host Business Strategy Conference Call on February 7
8. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
11. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNewswir...today it is acquiring the assets of Hyland Seeds, ...io. The addition of Hyland Seeds will further expa... company anticipates the introduction of SmartSta...Tolerant Trait Technology in corn in 2012. The tra...
(Date:11/24/2009)... Health care employment grew by 29...ly one to show consistent growth during the U.S. r... remain in trouble, and health systems are coming ..., instead of just administrators. , ...e employment continued growing in October despite ...
(Date:11/24/2009)..., SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstC...rmaceutical company focused on developing and comm...nced today that Anthony DiTonno, President and Chi...he 21st Annual Piper Jaffray Health Care Conferenc...alace Hotel in New York, New York. ,, Mr. DiTo...
(Date:11/24/2009)... The FBI recently approved the Prome...participating in or generating DNA records for the... Madison, WI USA (PRWEB) -- The FBI recently a...for use by laboratories participating in, or gener...em (NDIS). NDIS currently contains more than seven...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...me Therapeutics, Inc.,(Nasdaq: HALO ), a biopharm...roducts targeting the extracellular matrix for the...ology markets, today reported financial,results fo...08., "The fundamentals for Halozyme have never be...f our Phase 2 insulin clinical trial. The,study wi...
...re-FirstCall/ - Dr. Brad Thompson, President,and C...NCY), will present a,corporate overview of the Com...e Conference on Tuesday, November 11, 2008 at 11:1...Palace Hotel from November 10-12, 2008., A live a... at:, http://www.wsw.com/webcast/rrshq14/oncy or ...
...ate Highlights:, * Submitted NDA with FDA for NGX... with PHN, * Responded to EM...er review for NGX-4010 in peripheral neu...sX, Inc.,(Nasdaq: NGSX ), a biopharmaceutical com...el pain management therapies, today reported resul...
Other Biology Technology:Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 2Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 3Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 4Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 5Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 6Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 7Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 8Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2NeurogesX Reports Third Quarter 2008 Results 2NeurogesX Reports Third Quarter 2008 Results 3NeurogesX Reports Third Quarter 2008 Results 4NeurogesX Reports Third Quarter 2008 Results 5NeurogesX Reports Third Quarter 2008 Results 6NeurogesX Reports Third Quarter 2008 Results 7NeurogesX Reports Third Quarter 2008 Results 8NeurogesX Reports Third Quarter 2008 Results 9
(Date:11/25/2009)...Scientists at the California Institute of Technolo...e emotion-like behavior in the fruit fly, Drosoph...e relevant to the relationship between the neurotr...vity disorder (ADHD), are described in the Decembe...la brain contains only about 20,000 neurons and h...
(Date:11/25/2009)...teria don,t have easy lives. In addition to mammal...e natural enemies called bacteriophages, viruses t.... , Still, bacteria and another class of microo...me environments such as deep-sea volcanic vents) m...ave a built-in defense system that helps protect t...
(Date:11/25/2009)...sch, Head of the Cell Death Research Laboratory in...has been awarded the prestigious Johnson & Johnson...the cause of brain cell damage in Parkinson,s dise...ntists in support of innovation and excellence in ...ferred earlier this month at an event at the Hyatt...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New Report Emphasizes Critical Role of Including Early and Preventative Care for Women in Health Care Reform 48963 1New Report Emphasizes Critical Role of Including Early and Preventative Care for Women in Health Care Reform 48963 2Insmed CEO Resigns Due to Health Concerns 12633 1Insmed CEO Resigns Due to Health Concerns 12633 2Insmed CEO Resigns Due to Health Concerns 12633 3Colonoscopy Risks Increase With Age and Illness 48960 1Colonoscopy Risks Increase With Age and Illness 48960 2Colonoscopy Risks Increase With Age and Illness 48960 3
...EAGAN, Minn., March 11 Lockheed Martin has receiv...de performance-based logistics support for the AN/...t provides Q-70 logistics and supply support at ov...h options for additional support over the next fou...ue to $72 million. , , This contract follows a re...
... (SAN DIEGO) Central line-associated bloodstream ...uring the past three years at the Hospital of the ...approach combining leadership initiatives, electro...ne insertion and maintenance, and implementation o...ractices in line care. The findings, which Penn ph...
... LAS VEGASExplosive population growth in southern... water resources. In 2007, 80% of the state,s resi...on approached two million people. The dual concern...res frequent severe drought conditions has created...ernative water resources to meet resident and visi...
Other Biology News:U.S. Navy Awards Lockheed Martin Six-year Contract Worth Up to $72 Million for Advanced Display Systems Support 2Penn medicine draws road map for elimination of central line-associated bloodstream infections 2Penn medicine draws road map for elimination of central line-associated bloodstream infections 3Keeping golf courses green when fresh water is limited 2Keeping golf courses green when fresh water is limited 3
Mouse Anti-RYK Monoclonal Antibody, Unconjugated, Clone F30 P7 D7 F5 from Abcam
Pancreatic Cell Cryopreservation Medium from CHEMICON
Mouse Anti-S100 alpha Monoclonal Antibody, Unconjugated, Clone SH-A1 from Abcam
FCS File Sanitizer from Verity Software House
Biology Products: